1
项与 TROP2-CAR-NK(M.D. Anderson Cancer Center) 相关的临床试验Phase I/II Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
To find the recommended dose of TROP2- CAR-NK given intraperitoneally (directly into the abdominal cavity) to patients with highgrade serous ovarian cancer that has not responded to previous treatment or is resistant to treatment.
100 项与 TROP2-CAR-NK(M.D. Anderson Cancer Center) 相关的临床结果
100 项与 TROP2-CAR-NK(M.D. Anderson Cancer Center) 相关的转化医学
100 项与 TROP2-CAR-NK(M.D. Anderson Cancer Center) 相关的专利(医药)
100 项与 TROP2-CAR-NK(M.D. Anderson Cancer Center) 相关的药物交易